Related by context. All words. (Click for frequent words.) 71 targeted radiotherapeutic 70 candidate REP# 70 ionotropic glutamate receptor antagonists 69 Solazed TM 69 Aganocide 68 molecular imaging radiopharmaceutical 68 acetonide FA 68 Alfacell proprietary ribonuclease 68 Zemiva TM 68 topical antifungal 68 muscarinic receptor agonist 68 polysaccharide polymer 68 therapeutic monoclonal antibody 67 delivers fluocinolone acetonide FA 67 Intermezzo ® zolpidem tartrate 67 Anturol ® 67 rxRNA 67 Prednisporin 67 histone deacetylase HDAC 67 molecular chaperone regulation 67 Kosan dependence 67 Auxilium transmucosal film 67 using VIAdel TM 67 anti botulism antibody 66 PNP inhibitor 66 ALTROPANE R 66 DOS# 66 PDE4 inhibitor 66 overactive bladder AA# 66 ALN PCS 66 topical anti infective 66 SinuNase ™ 66 muscarinic receptor agonists 66 Iluvien ® 66 Acetavance TM intravenous acetaminophen 66 lead molecular radiotherapeutic 66 CEQ# 66 PORxin TM 66 EcoNail TM 66 Adnectin 66 novel therapeutic antibodies 66 Opterone R 66 SynCon 65 systemic RNAi 65 TELINTRA R 65 ALN TTR# 65 IMiDs R 65 novel L DOS# 65 intranasal insulin product 65 IMPDH inhibitor 65 toenail onychomycosis 65 BHT DNA 65 Panzem R 65 immunotherapeutic approaches 65 candidates Azedra TM 65 proprietary PEGylation 65 proprietary intranasal insulin 65 active cellular immunotherapy 65 Dendreon investigational 65 Chimigen TM 65 Trofex TM 65 isoform selective 65 developing TB4 65 Surfaxin LS 65 EndoTAG TM 65 HCV NS3 protease 65 ASONEP TM 65 AAG geldanamycin analog 65 DPX Survivac 65 Oral NKTR 65 Onalta TM 64 Onalta ™ 64 infectious diseases autoimmune diseases 64 targeting Inflammatory Bowel 64 oral prodrug 64 candidate deforolimus 64 HEPLISAV ™ 64 Zemiva TM Trofex TM 64 MKC# MT 64 PLK1 SNALP 64 TBC# 64 Allovectin 7 r 64 include GALNS N 64 sapropterin dihydrochloride Phase 64 IMiDs ® 64 DiLA2 64 anticoagulant reversing agent 64 PDX pralatrexate 64 tubulin inhibitor 64 oral picoplatin 64 AdVac ® 64 novel immunomodulatory 64 Iluvien TM 64 pipeline GlycoPEG GCSF 64 AMPK activators 64 Spiegelmer ® 64 Initiates Clinical 64 selectin antagonist 64 Occlusin TM 64 proprietary Isolagen Process 64 CD# CEA 64 kidney urologic 64 DP VPA 64 molecular imaging radiopharmaceuticals 64 Unit Dose Budesonide 64 Posiphen TM 64 Solazed 64 polymer conjugate technology 63 Tß4 63 include PLX IBD 63 Potelligent Technology 63 Personalized Immunotherapy 63 XP# XP# 63 anticancer therapeutics 63 Bellicum 63 novel RNAi therapeutics 63 modified glutathione analog 63 TOCOSOL Camptothecin 63 XL# anticancer compounds 63 THR beta agonist 63 sapacitabine CYC# 63 Generx TM 63 HuMax TAC 63 VitiGam 63 ATL# [002] 63 Synavive ™ 63 human C1 inhibitor 63 thrombin component 63 antibacterial therapeutics 63 Initiates Phase II 63 AzaSite Plus 63 SinuNase TM 63 TÎ ² 4 63 XL# XL# 63 fusion enhancers 63 Trofex ™ 63 Curaxin 63 topically applied SEPA 63 Maxy G# 63 concerning CombinatoRx 63 mitogen activated ERK kinase 63 Receives Orphan Drug 63 lintuzumab SGN 63 candidate TNFerade biologic 63 lipid nanoparticle LNP 63 proprietary DuraSite ® 63 siRNA therapeutic 63 IMA# 63 Pruvel 63 IMiDs ® compound 63 clinical trials dacetuzumab SGN 63 RNAi therapeutic targeting 63 candidate NGX 63 oral beclomethasone dipropionate 63 HepeX B TM 63 novel antiviral therapeutics 63 Xcytrin R 63 TKM PLK1 63 Anidulafungin 63 Etubics 63 HuCNS SC ® 63 EHT AGN 63 Crofelemer budesonide foam 63 PI3K/Akt pathway inhibitor 63 Receives Orphan Drug Designation 63 Anticalins R 63 MTP inhibitor 63 MKC# MKC# PP 63 novel immunotherapies 63 topical antifungal product 63 delivered RNAi therapeutic 63 GVAX ® 63 DNA methyltransferase inhibitors 63 MT#/MEDI-# 63 Presents Preclinical Data 63 Panzem R NCD 63 JAK inhibitors 63 KL4 Surfactant 63 Evoltra ® 63 liposomal formulation 63 Currently RegeneRx 63 OXIGON TM 62 Trastuzumab DM1 62 anti infective treatments 62 Oracea TM 62 Tarmogen 62 ALN TTR 62 Zemiva ™ 62 compound AEOL # 62 selective estrogen receptor modulator 62 include Phenoptin TM 62 photodisinfection 62 immatics 62 anti secretory 62 next generation URAT1 62 AFFITOME R 62 carbohydrate polymer 62 JAK2 Inhibitor 62 TKB# 62 Hsp# Inhibitor 62 liposomal delivery 62 BENLYSTA ® 62 Nektar proprietary 62 ZFP Therapeutics 62 Metallophile ™ Technology 62 platform HDL Mimetic 62 Prodarsan R 62 reformulates existing FDA 62 recombinant subunit vaccine 62 metastatic carcinoid 62 Bioral Amphotericin B 62 non nucleoside HCV 62 successfully commercialize Iluvien 62 Aviptadil 62 therapeutic monoclonal antibodies 62 NTDDS 62 Provectus Pharmaceuticals specializes 62 sores onychomycosis nail 62 HCV protease inhibitors 62 BEMA Granisetron 62 Anavex #-# 62 SPL# Gel vaginal microbicide 62 Initiate Clinical Trial 62 GERD migraine headaches 62 include VALSTAR TM 62 Captisol ® 62 developing oral talactoferrin 62 Myocet 62 TOCOSOL 62 Antibody Drug Conjugate 62 Fleximer 62 potentially treat nephropathic 62 Micromet proprietary BiTE 62 CORT # estimates 62 Homspera TM 62 chemically modified siRNA 62 targeted antifolate 62 Romidepsin 62 Nanobody R 62 Shigamabs ® 62 non porcine pancreatic 62 Sangamo ZFP technology 62 Sudhir Agrawal D.Phil 62 Alnylam #x# 62 defensin mimetic antibiotic 62 DIFICID ™ 62 novel histone deacetylase 62 IAP inhibitors 62 HCV RNA polymerase 62 developing Zerenex ferric 62 HQK 62 oral proteasome inhibitor 62 AzaSite Xtra 62 SynCon TM DNA 62 ILUVIEN ® 62 CB2 selective 62 humanized therapeutic 62 novel oral anticoagulant 62 orally administered inhibitor 62 Liprotamase 62 metaglidasen 62 staphylococcal vaccines 62 JZP 62 MediGene focuses 62 Nanobody 62 HepeX B 62 Loramyc TM 62 non nucleoside inhibitor 62 DPOLT 62 ABL inhibitor 62 TKM ApoB 62 romidepsin novel 62 epothilones 62 MVA BN R 62 DCVax R 62 ovarian cancer chronic hepatitis 62 tyrosine kinase inhibitor TKI 62 Trofex 62 RenaZorb TM 62 TM Aganocide 62 recombinant biopharmaceutical 62 OvaRex R 62 Archexin 62 CytRx oncology 62 selective orally bioavailable 62 oncolytic vaccine 62 CYT# potent vascular disrupting 62 volociximab 62 pharmacogenomic translational research 61 orBec R oral beclomethasone 61 Onalta 61 ocular formulation 61 motexafin gadolinium Injection 61 NeuroHealing 61 oral ghrelin agonist 61 NPC 1C 61 candidates Azedra 61 Initiates Clinical Trial 61 pharmacological chaperone 61 darinaparsin ZIO 61 Peginterferon alfa 2b 61 faropenem medoxomil 61 humanized monoclonal antibodies 61 Daclizumab 61 Locked Nucleic Acid 61 CCR9 antagonist 61 SNALP technology 61 Soliris eculizumab 61 ospemifene 61 sterile lidocaine patch 61 angina nausea 61 PORxin TM platforms 61 oral taxane 61 Idera Pharmaceuticals 61 cyclophilin inhibitors 61 intravenous iclaprim potent 61 Reports Preclinical Data 61 novel peptides 61 commercialize CorMedix drug 61 leading oral taxane 61 KSP inhibitor 61 SinuNase TM novel 61 PHX# 61 candidate ATHX 61 Files IND 61 iSONEP TM 61 adrenergic regulation 61 targets Galectin receptors 61 Collategene 61 torezolid phosphate 61 P#X# antagonist 61 molecular therapeutics immunotherapies 61 novel anticancer 61 proprietary BiTE ® 61 REG2 Regado 61 COX Inhibiting Nitric Oxide 61 Perflubutane Polymer Microspheres 61 AKT inhibitor 61 M# rationally 61 Novavax VLP vaccine 61 psoriasis rheumatoid arthritis 61 proprietary HuCNS SC 61 Bioral 61 anti CD3 monoclonal 61 nitric oxide donating 61 neuropathic pain metabolic diseases 61 Peyronie disease Frozen Shoulder 61 JAK1 61 Aganocide ® 61 acne impetigo 61 SNALP 61 multi kinase inhibitor 61 patented DepoVax TM 61 ARRY # 61 Alzhemed TM 61 LNP formulations 61 ZK EPO 61 Dyax phage display 61 Chimigen 61 YONDELIS R 61 diagnostic molecular imaging 61 treats acute lymphoblastic 61 CRTH2 61 HGS ETR1 mapatumumab 61 PEGylated 61 oral salmon calcitonin 61 Tyzeka Sebivo 61 RhuDex ® 61 Fc fusion protein 61 nasal decolonization 61 patented Bioral 61 MCSP respectively 61 intranasal formulation 61 TPI ASM8 61 AzaSite ISV 61 CAMPATH R 61 EVIZON ™ 61 dacetuzumab SGN 61 clinical trials Archexin 61 investigational humanized monoclonal antibody 61 proprietary biomaterials 61 Panzem ® 61 enhance ApoA 61 Bellicum Pharmaceuticals Inc. 61 Factor VIIa 61 treat chronic sinusitis 61 SparVax ™ 61 theranostic 61 Angiocept 61 proteasome inhibitor 61 luliconazole 61 Avian Transgenic Technology 61 Pentad TM 61 Litx 61 Cardio Vascu Grow 61 Nicotine Conjugate Vaccine 61 SynCon TM 61 therapeutics diagnostics 61 Canvaxin TM 61 humanized monoclonal 61 Cathepsin S 61 prokinetic agent 61 oral dihydropyrimidine dehydrogenase DPD 61 RONDEL ™ 61 Tekmira SNALP technology 61 targeting PCSK9 61 Amigal TM 61 Azedra TM Onalta TM 61 monoclonal antibody therapeutics 61 PrevOnco ™ 61 Aurora kinase inhibitor 61 biologic therapeutics 61 ALN HPN 61 infectious diseases autoimmune 61 pafuramidine maleate 61 Presents Preclinical 61 AtuPLEX 61 Alzheimer disease cognitive dysfunction 61 MOVIPREP R 61 MAXY VII 61 Prednisporin TM 60 DiLA 2 60 RNAi therapeutic platform 60 Anticalin R 60 avian influenza viral infections 60 AGS PSCA 60 XL# XL# XL# XL# 60 vinca alkaloid 60 flu mAb 60 Successfully Completes Phase 60 SuperAntibody 60 proven DuraSite ® 60 TransVax ™ 60 targeting CD# 60 JAK#/JAK# 60 Initiates Dosing 60 personalized cellular immunotherapy 60 candidate Zemiva TM 60 fibrosis IPF 60 Tekmira lipid nanoparticle 60 include Altastaph TM 60 NU# direct 60 Squalamine 60 NovaBay Aganocide compounds 60 immunotherapeutic vaccine 60 TRACON Pharmaceuticals 60 DermaVir Patch 60 oncology therapeutics 60 Telatinib 60 AtuRNAi 60 SCIB1 60 mertansine 60 Fx #A 60 Initiates Enrollment 60 ALN RSV program 60 immuno inflammatory 60 NS5b 60 biotherapeutic drugs 60 PDE4 modulators 60 AFREZZA ® 60 proprietary BiTE R 60 DNAi 60 inhaled liposomal ciprofloxacin 60 Acetylon 60 tezampanel NGX# 60 synthetic siRNA 60 inflammatory autoimmune diseases 60 PER.C6 ® production 60 Epothilones 60 advanced polymer conjugate 60 HDL Mimetic Peptide 60 Civacir 60 OMNARIS HFA 60 RNA antagonists 60 colorectal bladder 60 resorbable biomaterials 60 topical non steroidal 60 Nanobody ® 60 staphylococcal vaccine 60 Chemophase 60 Hepatitis C Virus HCV 60 PEG uricase 60 oncolytic virus therapies 60 Pancreate 60 MDRNA proprietary 60 Receptos 60 HEPLISAV Phase 60 VitiGam TM 60 Shigatoxin producing E. coli 60 Ophthotech 60 phage display technology 60 DepoVax TM 60 Affilin ® 60 Exelixis compounds 60 CCR5 antagonist 60 Hematide ™ 60 ATRA IV 60 TRX1 60 OraTest R 60 Endotis 60 superparamagnetic iron oxide nanoparticles 60 generation URAT1 inhibitor 60 acyclovir Lauriad R 60 VEGFR2 inhibitor 60 R roscovitine 60 CYT# vascular disrupting 60 human antibody therapeutics 60 vosaroxin 60 immunosuppressant therapies 60 anionic backbone 60 synthetic anti infective 60 TRIOLEX HE# 60 sirtuin therapeutics 60 novel emulsion formulation 60 R sorafenib tablets 60 PGL# 60 Excellagen TM 60 TRAIL receptor antibodies 60 Solazed ™ 60 synthetic peptide containing 60 CMV vaccine 60 antimitotic 60 BiovaxID TM 60 DermaVir 60 Sangamo ZFP TF 60 NurOwn 60 HCV protease inhibitor 60 StemEx R 60 BIM #A# 60 Memryte 60 insomnia migraine headaches 60 fibrin derived 60 selective immunoproteasome inhibitor 60 candidate XP# 60 BCR ABL inhibitors 60 SMIP 60 EP #R 60 commercialize Aganocides 60 VivaGel ™ 60 catalytic antioxidant compounds 60 Qutenza TM 60 lipopeptide 60 virosome 60 ART# 60 Cardioxyl 60 investigational pan BCR 60 DsiRNA 60 StaphVAX R 60 clinical trials lintuzumab SGN 60 Cerashield 60 histone deacetylase HDAC inhibitor 60 antibody fragment therapeutics 60 immunologic diseases 60 ArQule Kinase Inhibitor Platform 60 oral PTH 60 compound PMX # 60 Syntonix 60 hyaluronidase enzyme 60 Allovectin 7 R 60 methylnaltrexone bromide 60 proprietary PharmacoSurgery ™ 60 recombinant polyclonal antibodies 60 oral isotype selective HDAC 60 diarrhea predominant irritable 60 vapreotide acetate 60 VentiRx 60 TransVax tm 60 sodium glucose transporter 60 clinically differentiated 60 topical anti infectives 60 Antigenics QS 60 HDL Selective Delipidation 60 pan HDAC inhibitor 60 CB2 selective receptor agonist 60 valtorcitabine 60 Novosom 60 Kuvan TM sapropterin 60 Celator 60 Vascular Wrap TM 60 MT# MEDI 60 Accelerated Intelligent 59 orBec ® oral beclomethasone 59 FOLOTYN ® 59 orally bioavailable 59 avian transgenic 59 Ceragenin ™ 59 Hedgehog antagonist 59 Maribavir 59 patented NanoStat ™ 59 Kuvan R 59 Generx ™ 59 taxane derivative 59 HuLuc# 59 Familial Adenomatous Polyposis FAP 59 GLP toxicology studies 59 Rosetta Genomics Nasdaq ROSG 59 transthyretin mediated amyloidosis ATTR 59 sirtuin modulators 59 Anticalin ® 59 histone deacetylase inhibitor 59 ARIKACE ™ 59 neuro inflammatory disorders 59 2 methoxyestradiol 59 Optiquel ™ 59 oral Hsp# inhibitor 59 Provenge sipuleucel T 59 accumulate preferentially 59 Immunotherapeutic 59 Phase IIb clinical trials 59 Fleximer R 59 oncology immunology 59 Luteinizing Hormone Releasing Hormone 59 developing ostarine selective 59 visit www.genenews.com 59 vascular disrupting agents 59 sumatriptan DosePro 59 radiotherapeutic 59 TLR9 agonist 59 PARI Pharma focuses 59 ApoB SNALP 59 InterfeRx 59 SNT MC# 59 HCV NS5B polymerase 59 product platforms AZX# 59 ACAPODENE TM 59 commercializing anti infective 59 SynCon ™ DNA 59 personalized dendritic 59 Begins Dosing 59 FluCide 59 sulfonylhydrazine class 59 BrachySil TM 59 Vaxfectin R adjuvant 59 peptibody 59 platinum chemotherapeutic 59 RECOTHROM R 59 Zenvia ™ 59 gastro intestinal inflammation 59 Protexia ® 59 topical dermatology 59 TRIOLEX ™ 59 Nasulin ™ 59 Onconase 59 novel anti infective 59 apoptosis inducer 59 AdhTAP 59 IMPACS R 59 Vaccine Adjuvant 59 peptidomimetic 59 Pafuramidine 59 PEG irinotecan 59 Idera Pharmaceuticals develops 59 Ostabolin C TM 59 addressing idiopathic pulmonary 59 aerosolized AAT 59 HyperAcute 59 selective androgen receptor modulator 59 forodesine hydrochloride 59 essential thrombocythemia ET 59 Vaxfectin ® 59 HCV antiviral 59 chemotherapy induced neutropenia 59 drug ISA# 59 Chemokine Therapeutics 59 OMP #R# 59 SAR# [004] 59 biodefense pathogens 59 Diamyd R 59 NASDAQ BTRX pharmaceutical 59 Antigen Express comprise immunotherapeutics 59 Announces Poster Presentations 59 mucosal vaccines 59 cathepsin K inhibitor 59 Mpex 59 Panzem 59 IMC #B 59 antiangiogenesis therapies 59 TLR9 agonist IMO 59 Juvaris BioTherapeutics 59 mGluR5 NAM 59 topical gel containing 59 Vascular Disrupting Agent 59 IAP inhibitor 59 herpes labialis cold 59 hypoxia activated prodrug 59 utilizes InSite Vision 59 MAb therapy 59 Howard H. Pien 59 Phase #b/#a clinical 59 personalized immunotherapy 59 Inovio DNA 59 Arno Therapeutics 59 DepoVax ™ vaccine 59 small molecule thrombopoietin 59 unique PER.C6 59 cosmetic cosmeceutical products 59 histamine dihydrochloride 59 Inc. www.micromet inc.com 59 immune modulating 59 S1P antibody 59 NP2 Enkephalin 59 Submits Response 59 negative allosteric modulator 59 inhaled AAT 59 Lixivaptan 59 trastuzumab DM1 T DM1 59 activated collagen gel 59 Psoraxine R 59 Georges Gemayel 59 diabetes irritable bowel 59 Bavarian Nordic patented 59 hormone LHRH antagonist 59 carcinoid syndrome diabetes 59 peptide conjugated 59 include HEPLISAV hepatitis 59 Receives Fast Track 59 TRO# 59 Micromet BiTE 59 PEGylation technology 59 NADiA 59 Charlesson 59 gel formulations 59 HDL Therapy 59 M Enoxaparin 59 tkRNAi 59 evaluating satraplatin 59 novel VDA molecule 59 adrenal steroid hormones 59 HSP# inhibitor 59 unique PER.C6 ® 59 non nucleoside 59 MAXY G# 59 NeuroSTAT ® 59 REMUNE R 59 selective kinase inhibitors 59 technology visit http:/www.genmab.com 59 selective kinase inhibitor 59 Excellagen 59 biosurgical 59 erlotinib Tarceva R 59 Therapeutic Vaccine 59 oncological indications 59 Captisol enabled 59 selective androgen receptor modulators 59 biodefense vaccines 59 AFFiRiS 59 novel topoisomerase 59 Novavax VLP 59 DiLA2 Platform 59 prostone 59 proprietary bioresorbable polymer 59 Bioaccelerate compounds under 59 faropenem 59 incyclinide 59 A3 adenosine receptor 59 PANVAC VF 59 treat refractory angina 59 chimeric monoclonal antibody 59 thetreatment 59 siRNA therapeutics 59 ATL# [001] 59 PDE# inhibitors 59 RECALL VAX TM 59 romazarit 59 acid phosphatase PAP 59 POTELLIGENT ® 59 using ImmunoGen TAP 59 cancer immunotherapies 59 Selzentry Celsentri 59 Axentis Pharma 59 drug GLPG# 59 INS# [001] 59 docetaxel Taxotere R 59 rhFVIIa 59 ASONEP ™ 59 Aflibercept 59 Protectans 59 Veronate R 59 Sphingomab TM 59 INSPIRE Trial Phase III 59 INxin TM 59 epothilone 59 potently inhibit 59 ZaBeCor 59 CTAP# Capsules 59 Allovectin 7 59 RNAi therapeutic targeting PCSK9 59 Pradefovir 59 Exherin 59 tosedostat 59 Solzira ™ 59 calcium phosphate nanotechnology CaP 59 RhuDex R 59 PORxin 59 NeutroSpec TM 59 rusalatide acetate 59 AdVac 58 Naglazyme R 58 fibrotic disorders 58 tiapamil 58 OTC BB PVCT 58 Completes Patient Enrollment 58 CTLA4 Ig product 58 myelofibrosis polycythemia vera 58 Harry Palmin President 58 LentiVector technology 58 Aganocide TM 58 Isis antisense 58 DETERx ™ 58 Aeolus Pharmaceuticals Announces 58 Combivir Kivexa 58 immunotherapeutic agent 58 OvaRex ® MAb 58 LymphoStat B belimumab 58 miRNA biomarkers 58 MORAb 58 radiation sensitizer 58 LGLS 58 Cerashield ™ 58 Sphingomab 58 mTOR mammalian target 58 apricitabine ATC 58 Altastaph 58 Preclinical studies suggest 58 Restoraderm 58 Curaxins 58 Insegia 58 plasmid DNA pDNA 58 non nucleoside polymerase 58 ® bortezomib 58 EGEN 58 GelVac ™ 58 Capsulution 58 Medidur ™ FA 58 Bezielle 58 LEAPS TM 58 iSONEP ™ 58 Vaxfectin 58 PrevOnco 58 Fodosine 58 Aerosurf 58 itraconazole Sporanox 58 HSP# inhibitors 58 AdVac R 58 induced mucositis 58 NEUMUNE 58 Zoraxel TM 58 Vincent Mutel CEO 58 SAR# [002] 58 including eniluracil ADH 58 Tβ4 synthetic copy 58 proprietary LNA 58 TLR antagonists 58 siRNA sequences 58 oncologic diseases 58 nephropathic cystinosis 58 ASG 5ME 58 novel orally bioavailable 58 antibody MAb 58 Submits Biologics License Application 58 Zalypsis 58 refractory chronic lymphocytic 58 NanoTab 58 agonistic human 58 oral Janus kinase 58 MAXY alpha 58 A1PI 58 CINtec R 58 oxybutynin ATD TM 58 receptor tyrosine kinase inhibitor 58 Homspera ® 58 XmAb 58 EVIZON TM 58 KemPharm 58 Eligen ® Technology 58 biocompatible coatings 58 Hematide TM 58 Transdel TM platform 58 Prodarsan ® 58 lexidronam injection 58 Cyclosert TM 58 patented DepoVax ™ 58 markets Testim ® 58 TransVax TM 58 Polyphenon ® E 58 oral talactoferrin 58 Cannabinor 58 proprietary Vascular Targeting 58 HEPLISAV TM hepatitis B 58 castrate resistant prostate cancer 58 MorphoSys proprietary 58 commercialize deforolimus ARIAD 58 factor VIIa 58 TOPICA 58 Kiadis 58 GVAX cancer 58 ZEVALIN ® 58 pralatrexate injection folate analogue 58 selective S#P# receptor agonist 58 delta opioid receptor 58 systemic RNAi therapeutic 58 Cellerant 58 investigational hepatitis C 58 TELINTRA 58 JAK2 inhibitor 58 TRIOLEX HE# APOPTONE HE# 58 ESBA# 58 Dyax logo 58 REMOXY POSIDUR ELADUR 58 Pertuzumab 58 SansRosa 58 vinorelbine tartrate 58 ProLindac TM 58 RNA interference RNAi therapeutics 58 alvespimycin 58 molecular chaperone technology 58 neuro inflammatory 58 Exherin TM 58 Poly ICR 58 unproven preclinical 58 visit www.targanta.com 58 6 sulfatase 58 Small Modular SMIP 58 bioengineered vaccines 58 endothelin antagonist 58 Affibody 58 Hybridon 58 preclinical compounds 58 mediate RNAi 58 Behcet uveitis 58 ADP receptor antagonist 58 Tezampanel 58 ChimeriVax JE 58 Nautilus Biotech 58 Menadione 58 Relivar 58 Receives Milestone Payment 58 Rhucin ® recombinant 58 Vaccinex 58 Darinaparsin 58 Viprovex TM 58 synthetic retinoid 58 Linjeta TM 58 ddRNAi 58 BioFocus DPI Galapagos 58 LX# LX# LX# 58 cutaneous T 58 bavituximab monotherapy trial 58 HepDirect prodrug 58 XOMA 3AB 58 humanized antibodies 58 Granted Orphan Drug 58 KNS # 58 Soliris TM eculizumab 58 HuCAL antibodies 58 novel peptide 58 R#/MEM # 58 HuMax CD#b 58 Alocrest 58 semi synthetic lipoglycopeptide 58 PEG SN# 58 bladder ovarian 58 CoVal TM fusion 58 Amgen Kyowa Hakko Kirin 58 Cumulase 58 influenza VLP vaccine 58 Jeremy Curnock Cook 58 oral probiotic 58 Predictive medicine 58 recurrent metastatic ovarian cancer 58 IV APAP 58 Presents Positive 58 lipid nanoparticle 58 symbol AVXL 58 PEGylated interferon 58 Sebivo 58 Phase Ib clinical trials 58 docetaxel Taxotere ® 58 DURIN TM 58 Campath ® 58 visit www.genmab.com 58 MAGE A3 ASCI 58 Pepducin 58 delivers sumatriptan 58 anticancer compound 58 topical ophthalmic 58 RNA antagonist 58 RNAi Therapeutics 58 Dr. Bahcall 58 Enhanze 58 CCX# 58 Ferring Pharmaceuticals specializes 58 OnDose TM 58 var arrUrl = 58 intravenous AAT 58 palifosfamide Zymafos TM 58 Tesetaxel 58 MKC# 58 www.nanoviricides.com